Referências

  1. OHLIN, A. et al. Clinical signs and CRP values associated with blood culture results in neonates evaluated for suspected sepsis. Acta Paediatrica, Oslo, v. 99, n. 11, p. 1635-1640, 2010. DOI: 10.1111/j.1651-2227.2010.01913.x.
  2. BANG, A. T. et al. Simple clinical criteria to identify sepsis or pneumonia in neonates in the community needing treatment or referral. The Pediatric Infectious Disease Journal, Philadelphia, v. 24, n. 4, p. 335-341, 2005. DOI: 10.1097/01.inf.0000157094.43609.17.
  3. BEKHOF, J. et al. Clinical signs to identify late-onset sepsis in preterm infants. European Journal of Pediatrics, Heidelberg, v. 172, n. 4, p. 501-508, 2013. DOI: 10.1007/s00431-012-1910-6.
  4. PACE, E.; YANOWITZ, T. Infections in the NICU: neonatal sepsis. Seminars in Pediatric Surgery, Philadelphia, v. 31, n. 4, p. 151200, 2022. DOI: 10.1016/j.sempedsurg.2022.151200.
  5. CLARK, R. H. et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics, Elk Grove Village, v. 117, n. 1, p. 67-74, 2006. DOI: 10.1542/peds.2005-0179.
  6. CHEN, X. K. et al. Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants. Antimicrobial Agents and Chemotherapy, Washington, v. 62, n. 4, p. e02448-17, 2018. DOI: 10.1128/AAC.02448-17.